Authors


Soleyah Groves, MD

Latest:

Service Line Care Delivery Model for COVID-19 Patient-Centric Care

The authors provide steps hospitals can take to align their care delivery model to effectively meet the demands of a public health crisis such as the current pandemic.


Lisa Engel, MA, BA

Latest:

Implementing Multistate Behavioral Health Pay-for-Performance Initiatives in Medicaid Managed Care

The authors describe a pay-for-performance initiative targeting behavioral health providers, which was introduced by a large Medicaid managed care organization across multiple states.


Rita de Cassia Castro, MD

Latest:

Baloxavir vs Oseltamivir: Reduced Utilization and Costs in Influenza

Baloxavir, compared with oseltamivir, was associated with lower health care resource utilization and costs in patients with influenza, particularly those at high risk of secondary complications.


Stephen Schondelmeyer, PharmD, PhD

Latest:

Provider Barriers in Uptake of Biosimilars: Case Study on Filgrastim

Previous studies have found modest uptake of biosimilars in both commercial and Medicare populations. This study finds that the uptake varies between the rural and urban provider settings.



Jean Feng, PhD

Latest:

Reducing Readmissions in the Safety Net Through AI and Automation

Artificial intelligence (AI) and electronic health record–based automation tools helped a safety-net health system meet performance-based readmission metrics, thereby retaining critical funding while improving clinical and equity outcomes.


Martine C. Maculaitis, PhD

Latest:

Real-world Usage of Bevacizumab-bvzr Biosimilar in US Oncology Practice

Real-world adoption of bevacizumab-bvzr biosimilar was retrospectively assessed, revealing switching between biosimilars and the reference product and utilization in extrapolated indications and combination regimens.


Joseph R. Betancourt, MD, MPH

Latest:

Addressing Virtual Care Disparities for Patients With Limited English Proficiency

With increased use of virtual care due to the COVID-19 pandemic, the following recommendations address disparities for patients with limited English proficiency.


Enrico Repetto, MD

Latest:

Cost Analysis of Self-Monitoring Blood Glucose in Nonintensively Managed Type 2 Diabetes

Analysis of claims data showed reduced utilization and costs among patients with nonintensively managed type 2 diabetes using self-monitoring of blood glucose compared with continuous glucose monitoring.


Margaret I. Liang, MD, MS

Latest:

Cost Sharing for Oral Lenvatinib Among Commercially Insured Patients

Among a cohort of insured patients with cancer, the median total monthly cost of oral lenvatinib was $17,253, and 75% of patients paid $100 or less out of pocket per month for the drug.


Jill Feldman

Latest:

Adverse Effect Management in the COCOON Trial for EGFR-Mutated NSCLC: Jill Feldman

Jill Feldman, cofounder and president, EGFR Resisters, shares the importance of being proactive in managing dermatologic toxicities in epidermal growth factor receptor (EGFR)–positive lung cancer.


Parul Mistry, MD, MA

Latest:

Predicting Opioid Use Disorder and Associated Risk Factors in a Medicaid Managed Care Population

A Medicaid managed care organization developed a machine learning model to identify opioid use disorder (OUD) risk factors and predict OUD incidence in its multistate population.


Lindsay Dymowski

Latest:

Contributor: How Pharmacists and Providers Can Improve Patient Care

Pharmacists and pharmacies can be doing more to help with medication management for their patients.


Dr Matthew Matasar | Image Credit: Rutgers Cancer Institute
Matthew Matasar, MD

Latest:

Global Hematology Experts Reflect on Key Takeaways From the EHA 2025 Congress

At the 30th European Hematology Association (EHA) Congress, hematology experts highlight breakthroughs in treatment, the importance of patient voices, and challenges in making innovations accessible worldwide.



Jonathan T. Rawlins, MA

Latest:

Improving Pain Clinic Outcomes With Preappointment Surveys: Data-Driven Policy Change

Implementing a policy change to require preappointment surveys before scheduling initial clinic evaluations can improve wait-list times and show rates.


Deborah R. Kaye, MD, MS

Latest:

Systemic Treatments for Advanced Prostate Cancer: Relationship Between Health Insurance Plan and Treatment Costs

The authors examine how insurer and patient out-of-pocket payments for advanced prostate cancer differ by drug and health plan type and describe the relationship between these payments and utilization.


Andrew D. Schreiner, MD, MSCR

Latest:

Statin Prescribing Patterns in Patient-Centered Medical Home Patients With NAFLD

In this study, authors assessed the proportion of patients with nonalcoholic fatty liver disease (NAFLD) receiving prescriptions for statins in primary care.


James Motyka, PharmD

Latest:

Unintended Consequences of the Inflation Reduction Act: Clinical Development Toward Subsequent Indications

The Inflation Reduction Act will likely change incentives surrounding single-indication launches and postapproval research for additional indications in small molecule drugs, affecting patient access.


Sunny C. Lin, PhD, MS

Latest:

Bundled Payments Lead to Quality Improvements in Hospitals’ Skilled Nursing Facility Referral Networks

The Bundled Payments for Care Improvement program was associated with improved quality of skilled nursing facilities in hospital referral networks for patients undergoing surgery for joint replacement.


Arshad Rahim, MD, MBA

Latest:

Stakeholder Insights on rtCGM in T2D Population Health Management

Leading payer and health system stakeholders reviewed literature and shared insights on the value of real-time continuous glucose monitoring (rtCGM) in type 2 diabetes (T2D) population health.


Carolina Schinke, MD

Latest:

Trispecifics in Context: Hype vs Readiness

A panelist emphasizes that while trispecific antibodies offer near-perfect response rates and convenient monthly dosing that could improve quality of life, careful assessment of adverse effects like infections and taste disturbances is crucial—especially for lower-risk patients—making patient preference and physician judgment key in determining their optimal use, with high-risk patients with heavily pretreated disease poised to benefit most.


John Allan, MD

Latest:

Final Thoughts on Bispecifics in B-Cell Lymphomas From ASH 2024

Panelists share their final thoughts on bispecific therapies in B-cell lymphomas based on insights from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition 2024.



Micaela Mercado, PhD, LMSW

Latest:

Implementation of the Accountable Health Communities Model in Arizona

The Accountable Health Communities Model facilitates multisector coordination. Implementation science elucidated the contextual factors that facilitated the use of this model in Arizona.


Soo Borson, MD

Latest:

Utilization of Low- and High-Value Health Care by Individuals With and Without Cognitive Impairment

Low-value service utilization is common among all older adults, and utilization of some high-value services decreases after the onset of cognitive decline.


Richard Freeman, MD

Latest:

Successes and Failures With Bundled Payments in the Commercial Market

The relatively few examples of commercially funded condition-specific bundled payments provide insights into how to spread this alternative payment model further in the private insurance market.


Karen O. Moss, PhD, RN, CNL

Latest:

Integrating Primary Care and Public Health for Advance Care Planning

This article proposes a new model, Public-Primary ACP, that leverages coordination between primary care and public health workforces to improve delivery of advance care planning.


Kathryn Brignole, MSc

Latest:

Pervasiveness and Clinical Staff Perceptions of HPV Vaccination Feedback

This article used regression analyses to quantify how clinical staff perceive provider feedback to improve human papillomavirus (HPV) vaccination rates and determine the prevalence of such feedback.


Anuraag R. Kansal, PhD

Latest:

Cost-Effectiveness of a Multicancer Early Detection Test in the US

Multicancer early detection testing results in extended life-years and reduced cancer treatment costs through earlier diagnosis, leading to a cost-effective option in cancer screening.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo